New antiretroviral agents.

J. E. Gallant

Research output: Contribution to journalArticlepeer-review


Several new antiretroviral agents were discussed at the 6th Conference on Retroviruses and Opportunistic Infections. Some of the new agents described were nucleoside analog reverse transcriptase inhibitors (NRTIs), such as FTC and lodenosine (FddA). Non-nucleoside reverse transcriptase inhibitors (NNRTIs) were also presented and include AG 1549 (formerly S 1153) and DPC 961. In addition, some protease inhibitors (PIs) were mentioned. These PIs include ABT-378/r and AG 1776. A new fusion inhibitor, called T-20 (Trimeris), was also discussed.

Original languageEnglish (US)
JournalThe Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
Issue number2
StatePublished - 1999
Externally publishedYes


Dive into the research topics of 'New antiretroviral agents.'. Together they form a unique fingerprint.

Cite this